Anti-metastatic activity of ellagic acid is inhibition of the ACTN4 gene, which is responsible for breast cancer stem cell self-renewal and their metastatic abilities, and consequently for poor survival of breast cancer patients. The gene discussed is ACTN4; the disease is breast carcinoma.